Biomarker-driven assessment of immunochemotherapy with or without fruquintinib as first-line treatment for advanced gastric/GEJ adenocarcinoma: Initial clinical results and subgroup analysis from the MGC-FLORA study.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Fudan University, Fudan University Shanghai Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162517145
Cites:
Cited by:
Related to: